ALFA Filings
Every announcement, straight from the exchange
Every Bliss GVS Pharma management change announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Bliss GVS Pharma Limited appointed Hetul Mehta, Amar Shah, and Pramod Kasat as Non-Executive Directors. Simultaneously, Narsimha Shibroor Kamath resigned as Executive Director effective September 28, 2026.
Bliss GVS Pharma Ltd announced the resignation of Mr. Sachin Saboo, General Manager – Regulatory & Clinical, effective from the close of business hours on July 24, 2026.
Bliss GVS Pharma appointed Rahul Adakmol as CEO, effective July 15, 2026. Narsimha Shibroor Kamath stepped down as CEO but remains Managing Director.
Mr. Santosh Parab completed his final term as Independent Director on May 25, 2026. This planned leadership change follows statutory term limits for independent directors.
Bliss GVS Pharma Limited has appointed Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah as Additional Independent Directors for five-year terms effective April 03, 2026. Both appointees are seasoned finance professionals and Chartered Accountants. The appointments are subject to shareholder approval via postal ballot.